Artificially induced thyroid suppression in sickle cell disease.

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49

Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22

Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10

Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J Biol Chem (1984) 2.86

Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77

Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40

Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34

Haptoglobin: a natural bacteriostat. Science (1982) 2.23

Hemoglobin. A biologic fenton reagent. J Biol Chem (1984) 2.16

Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med (1980) 2.14

Multicellular oxidant defense in unicellular organisms. Proc Natl Acad Sci U S A (1992) 2.09

Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med (1993) 2.09

Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A (1998) 2.02

Elevated erythrocyte calcium in sickle cell disease. Nature (1973) 1.97

Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest (1982) 1.93

Hereditary catalase deficiencies and increased risk of diabetes. Lancet (2000) 1.93

Inflammatory responses to biomaterials. Am J Clin Pathol (1995) 1.89

Molecular basis of biomaterial-mediated foreign body reactions. Blood (2001) 1.87

Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem (1987) 1.78

Phytic acid. A natural antioxidant. J Biol Chem (1987) 1.75

Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion (1985) 1.71

Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70

Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68

Packed red blood cells. N Engl J Med (1969) 1.60

Antioxidant functions of phytic acid. Free Radic Biol Med (1990) 1.52

Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A (1988) 1.51

Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb (1991) 1.49

Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49

Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int (2006) 1.46

Skin color and nutrient photolysis: an evolutionary hypothesis. Science (1978) 1.43

Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest (1996) 1.36

Natural responses to unnatural materials: A molecular mechanism for foreign body reactions. Mol Med (1999) 1.34

Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med (1967) 1.34

Bacterial glutathione: a sacrificial defense against chlorine compounds. J Bacteriol (1996) 1.31

Lysosomal involvement in apoptosis. Redox Rep (2001) 1.31

Malaria parasites adopt host cell superoxide dismutase. Science (1983) 1.30

Inflammatory responses to implanted polymeric biomaterials: role of surface-adsorbed immunoglobulin G. J Lab Clin Med (1993) 1.30

The relationship between red cell 2,3-diphosphoglycerate and levels of hemoglobin in the human. Proc Natl Acad Sci U S A (1968) 1.30

Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene (2009) 1.28

Membrane abnormalities of irreversibly sickled cells. Semin Hematol (1979) 1.27

Erythrocyte catalase. A somatic oxidant defense? J Clin Invest (1986) 1.24

A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost (2004) 1.22

Hemoglobin potentiates central nervous system damage. J Clin Invest (1987) 1.19

Survival at extreme altitude: protective effect of increased hemoglobin-oxygen affinity. Science (1974) 1.19

Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum. Br J Haematol (1973) 1.19

Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest (1988) 1.15

Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med (1990) 1.15

Degradation of biomaterials by phagocyte-derived oxidants. J Clin Invest (1993) 1.13

Leishmanial superoxide dismutase: a possible target for chemotherapy. Biochem Biophys Res Commun (1981) 1.13

Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol (1994) 1.13

Catalase activity and red cell metabolism. Adv Exp Med Biol (1972) 1.11

Atypical antigenic properties of a gamma-A myeloma protein. J Immunol (1966) 1.11

Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med (1998) 1.10

Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 1.10

Hypohaptoglobinemia associated with familial epilepsy. J Exp Med (1985) 1.10

Antimalarial properties of orally active iron chelators. Blood (1988) 1.09

Superoxide dismutase amplifies organismal sensitivity to ionizing radiation. J Biol Chem (1989) 1.08

Host heme catabolism in drug-sensitive and drug-resistant malaria. J Lab Clin Med (1977) 1.08

Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest (1978) 1.08

Iron-containing superoxide dismutase from Crithidia fasciculata. Purification, characterization, and similarity to Leishmanial and trypanosomal enzymes. J Biol Chem (1983) 1.08

Hemolysis in dialized patients caused by chloramines. Nephron (1974) 1.07

Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion (1992) 1.07

Pathobiology of heme interaction with the erythrocyte membrane. Semin Hematol (1989) 1.07

Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med (1981) 1.06

Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci U S A (1997) 1.06

Calcium-induced damage of haemoglobin SS and normal erythrocytes. Br J Haematol (1978) 1.06

Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures. J Immunol (1977) 1.05

Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: a natural anti-inflammatory mechanism? J Lab Clin Med (1996) 1.05

Role of red cell 2,3-diphosphoglycerate in the adaptation of man to altitude. J Lab Clin Med (1969) 1.05

Apoptotic death of inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol (2001) 1.03

Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03

Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Prog Hematol (1973) 1.01

Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett (2001) 1.01

Oxidants, oxidant drugs, and malaria. J Med Chem (1988) 1.00

Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2? FEBS Lett (2000) 1.00

Erythrocyte metabolism: interaction with oxygen transport. Science (1971) 0.98

A spectrophotometric assay for chlorine-containing compounds. Anal Biochem (1991) 0.98

Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood (1999) 0.98

Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett (2001) 0.96

Immunologic findings in patients receiving methyldopa: a prospective study. J Lab Clin Med (1971) 0.96

Hemostatic alterations accompanying sickle cell pain crises. J Lab Clin Med (1976) 0.96

Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun (1998) 0.96

Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun (1985) 0.95

Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet (1985) 0.95

Dietary suppression of colonic cancer. Fiber or phytate? Cancer (1985) 0.95

Catalases and peroxidases and glutathione and hydrogen peroxide: mysteries of the bestiary. J Lab Clin Med (1991) 0.95

Albumin-binding surfaces for implantable devices. J Biomed Mater Res (1992) 0.94

A starch-gel electrophoretic method for the study of diaphorase isozymes and preliminary results with sheep and human erythrocytes. Biochem Biophys Res Commun (1967) 0.93

Suppression of colonic cancer by dietary phytic acid. Nutr Cancer (1993) 0.93

Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci U S A (1989) 0.92

Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients. Br J Haematol (1981) 0.92

Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises. Thromb Haemost (1980) 0.92

Current status of red-cell preservation and availability in relation to the developing national blood policy. N Engl J Med (1974) 0.91

Retention of water and potassium by erythrocytes prevents calcium-induced membrane rigidity. Am J Pathol (1978) 0.91

Acute iron poisoning. Rescue with macromolecular chelators. J Clin Invest (1989) 0.90

Purification and use of the C3d subunit C3. Transfusion (1976) 0.90

Further studies of the C3g component of the alpha 2D fragment of human C3. Clin Exp Immunol (1983) 0.90

Sodium-potssum tmulated ATPase activity of mammalian hemolysates: clinical observations and ominance of ATPase deficiency in the potassium polymorphism of sheep. J Lab Clin Med (1968) 0.89

The proper use of previously frozen red blood cells for transfusion. Blood (1982) 0.89

Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises. East Afr Med J (1989) 0.89